Enzo Biochem Inc (NYSE:ENZ)
$ 1.13 -0.04 (-3.42%) Market Cap: 57.88 Mil Enterprise Value: 4.83 Mil PE Ratio: 1.69 PB Ratio: 0.81 GF Score: 38/100

Enzo Biochem Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 22, 2022 / 07:00PM GMT
Release Date Price: $3.04 (+1.33%)
Harrison Schrage
KeyBanc Capital Markets - Analyst

Hello and welcome to KeyBanc's 2022 Healthcare Conference. My name is Harrison Schrage, and I'm an equity research associate on Paul Knight's life sciences team here in New York. Here, we'll be discussing Enzo Biochem with CEO Hamid Erfanian and CFO Dave Bench.

If anyone in the audience has any questions, please submit them in the question box below. We'll probably have time for a little bit of Q&A near the end of the session. So I'll be monitoring that. I guess, yeah, let's just dive right into it.

So Hamid and Dave, also, if you guys could just provide like a brief history of Enzo and kind of just a little bit of an overview of your segments today.

Hamid Erfanian
Enzo Biochem, Inc. - CEO

Okay, that sounds great. Again, this is Hamid Erfanian. Welcome and thank you for joining us. I've been with Enzo since November 8, 2022 -- in 2021. So that's going about four months. I'm excited to be here.

Brief overview of Enzo, the best way that I can share with you is it's a biotech

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot